Sign Up to like & get
recommendations!
0
Published in 2019 at "JAMA Cardiology"
DOI: 10.1001/jamacardio.2018.4566
Abstract: Importance In the Canakinumab Anti-inflammatory Thrombosis Outcome Study (CANTOS) trial, the anti-inflammatory monoclonal antibody canakinumab significantly reduced the risk of recurrent cardiovascular events in patients with previous myocardial infarction (MI) and high-sensitivity C-reactive protein (hs-CRP)…
read more here.
Keywords:
cost effectiveness;
recurrent cardiovascular;
canakinumab;
cardiovascular events ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "European Journal of Clinical Investigation"
DOI: 10.1111/eci.13533
Abstract: The relationship between anticardiolipin (aCL) antibodies and cardiovascular events is uncertain and may vary according to arterial location.
read more here.
Keywords:
location;
location recurrent;
recurrent cardiovascular;
anticardiolipin antibodies ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "BMC Medicine"
DOI: 10.1186/s12916-025-04279-5
Abstract: The extent to which healthy lifestyle factors influence recurrent cardiovascular events in obstructive sleep apnea (OSA) patients is uncertain. To evaluate the association between adherence to baseline healthy lifestyle and the risk of recurrent cardiovascular…
read more here.
Keywords:
recurrent cardiovascular;
healthy lifestyle;
osa patients;
save study ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Medicine"
DOI: 10.3389/fmed.2022.870906
Abstract: Introduction Obstructive sleep apnea (OSA) severity is based on the apnea-hypopnea index (AHI). The AHI is a simplistic measure that is inadequate for capturing disease severity and its consequences in cardiovascular diseases (CVDs). Deleterious effects…
read more here.
Keywords:
events patients;
component;
recurrent cardiovascular;
risk recurrent ... See more keywords